This is a prospective cohort study exploring a broadened use of ulipristal acetate as a
cervical preparation agent for second trimester surgical abortion. Specifically, this pilot
study will test the feasibility of using ulipristal as a pharmacologic cervical preparation
with adjunct misoprostol prior to surgical abortion.